Document Detail


Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models.
MedLine Citation:
PMID:  22366213     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Although in vitro studies have shown that nicotinic acid inhibits some aspects of the inflammatory response, a reduced number of in vivo studies have investigated this activity. To the best of our knowledge, the effects induced by nicotinic acid in models of nociceptive and inflammatory pain are not known. Per os (p.o.) administration of nicotinic acid (250, 500 or 1000mg/kg, -1h) inhibited the first and the second phases of the nociceptive response induced by formalin in mice. Nicotinic acid (250 or 500mg/kg, -1 and 3h) also inhibited the mechanical allodynia induced by Carrageenan in rats, a model of inflammatory pain. However, in a model of nociceptive pain, exposure of mice to a hot-plate, nicotinic acid was devoid of activity. In addition to inhibiting the nociceptive response in models of inflammatory pain, nicotinic acid (250 or 500mg/kg, p.o., -1 and 3h) inhibited paw edema induced by Carrageenan in mice and rats. Picolinic acid (62.5 or 125mg/kg, p.o., -1h), a nicotinic acid isomer, inhibited both phases of the nociceptive response induced by formalin, but not paw edema induced by Carrageenan in mice. The other nicotinic acid isomer, isonicotinic acid, was devoid of activity in these two models. In conclusion, our results represent the first demonstration of the activity of nicotinic acid in experimental models of nociceptive and inflammatory pain and also provide further support to its anti-inflammatory activity. It is unlikely that conversion to nicotinamide represents an important mechanism to explain the antinociceptive and anti-inflammatory activities of nicotinic acid. The demonstration of new activities of nicotinic acid, a drug that has already been approved for clinical use and presents a positive safety record, may contribute to raise the interest in conducting clinical trials to investigate its usefulness in the treatment of painful and inflammatory diseases.
Authors:
Adriana M Godin; Wallace C Ferreira; Leonardo Tadeu S Rocha; Raphael G Ferreira; André Luiz L Paiva; Leonardo A Merlo; Elias B Nascimento; Leandro Francisco S Bastos; Márcio M Coelho
Related Documents :
22774173 - The mechanism of amino acid activation: the work of mahlon hoagland.
2481323 - Alzheimer type dementia: diffuse type of senile plaques demonstrated by beta protein im...
2496683 - Regulation of pteridine biosynthesis and aromatic amino acid hydroxylation in drosophil...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-16
Journal Detail:
Title:  Pharmacology, biochemistry, and behavior     Volume:  -     ISSN:  1873-5177     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0367050     Medline TA:  Pharmacol Biochem Behav     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence that 2-aminoethoxydiphenyl borate provokes fibrillation in perfused rat hearts via voltage-...
Next Document:  Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain mo...